NCT00477880View on ClinicalTrials.gov

Cetuximab in Treating Patients With Ménétrier Disease at High Risk of Developing Stomach Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

April 30, 2001

Primary Completion Date

September 30, 2010

Study Completion Date

September 30, 2010

Conditions
Gastric CancerPrecancerous Condition
Interventions
BIOLOGICAL

Cetuximab

Trial Locations (3)

37064

Vanderbilt-Ingram Cancer Center - Cool Springs, Nashville

Vanderbilt-Ingram Cancer Center at Franklin, Nashville

37232-6838

Vanderbilt-Ingram Cancer Center, Nashville

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Vanderbilt University

OTHER

NCT00477880 - Cetuximab in Treating Patients With Ménétrier Disease at High Risk of Developing Stomach Cancer | Biotech Hunter | Biotech Hunter